Clinical Efficacy and Adverse Reactions of Bevacizumab plus Radiochemotherapy in the Treatment of Advanced Gastric Cancer

Table 4

Comparison of improvement in quality of survival between the two groups (n/%).

Groups	n	Improved	Stable	Decreased
Research group	43	18/41.86	19/44.19	6/13.95
Control group	43	9/20.93	24/55.81	10/23.26
χ^2		4.373	1.163	1.229
		0.037	0.281	0.268